Open Access<p>Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study</p>
Author(s) -
Sarah Subramanian,
Rammohan Prasanna,
Ghanashyam Biswas,
Saroj Kumar Das Majumdar,
Nisarg Joshi,
Deepak Bunger,
Mubeen Khan,
Imran Ahmad
Publication year - 2020
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.19
H-Index - 27
ISSN - 1179-1314
DOI - 10.2147/bctt.s236108
Subject(s) - medicine , docetaxel , breast cancer , neutropenia , metastatic breast cancer , adverse effect , chemotherapy , oncology , febrile neutropenia , leukopenia , anemia , cancer , clinical endpoint , gastroenterology , clinical trial
The purpose of this study was to evaluate the efficacy and safety of nanosomal docetaxel lipid suspension (NDLS, DoceAqualip)-based chemotherapy in breast cancer.